Challenges in creating an opt-in biobank with a registrar-based consent process and a commercial EHR

Residual clinical samples represent a very appealing source of biomaterial for translational and clinical research. We describe the implementation of an opt-in biobank, with consent being obtained at the time of registration and the decision stored in our electronic health record, Epic. Information...

Descripción completa

Detalles Bibliográficos
Autores principales: Marsolo, Keith, Corsmo, Jeremy, Barnes, Michael G, Pollick, Carrie, Chalfin, Jamie, Nix, Jeremy, Smith, Christopher, Ganta, Rajesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Group 2012
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3486732/
https://www.ncbi.nlm.nih.gov/pubmed/22878682
http://dx.doi.org/10.1136/amiajnl-2012-000960

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3486732/
https://www.ncbi.nlm.nih.gov/pubmed/22878682
http://dx.doi.org/10.1136/amiajnl-2012-000960

Ejemplares similares